The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis

Key Points:

• Certain laboratory parameters can serve as early predictors of the no-reflow phenomenon in STEMI patients after primary PCI.
• Identifying these biomarkers can help improve risk stratification and guide treatment strategies to enhance myocardial reperfusion.
• The study underscores the clinical importance of laboratory markers in optimizing patient outcomes post-PCI.